Depression Medicine Market Report

China Depression Medicine Industry Market Research Report 2023-2029

  • POSTDATE：Aug 26, 2023
  • PAGES：143
  • REPORT CODE：GMM1758267
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Depression Medicine industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Janssen Pharmaceuticals

    • Abbott Laboratories

    • Pfizer

    • Naurex

    • SK Biopharmaceuticals

    • GlaxoSmithKline

    • Luye Pharma

    • Otsuka Pharmaceutical

    • Gedeon Richter

    • Eli Lilly and Company

    • Novartis

    • AstraZeneca

    By Type:

    • Selective Serotonin Reuptake Inhibitors

    • Tetracyclic Antidepressants

    • Tricyclic Antidepressants

    • Benzodiazepines

    • Others

    • Monoamine Oxidase Inhibitors

    • Atypical Antipsychotics

    • Serotonin-norepinephrine Inhibitors

    By Application:

    • Others

    • Hospitals

    • Clinics

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Depression Medicine Market Overview 2018-2029

    • 1.1 China Depression Medicine Industry Development Overview

    • 1.2 China Depression Medicine Industry Development History

    • 1.3 China Depression Medicine Industry Market Size (2018-2029)

    • 1.4 China Depression Medicine Market Analysis by Type from Production Side

      • 1.4.1 China Depression Medicine Production Volume, Production Value and Growth Rate of Selective Serotonin Reuptake Inhibitors (2018-2029)

      • 1.4.2 China Depression Medicine Production Volume, Production Value and Growth Rate of Tetracyclic Antidepressants (2018-2029)

      • 1.4.3 China Depression Medicine Production Volume, Production Value and Growth Rate of Tricyclic Antidepressants (2018-2029)

      • 1.4.4 China Depression Medicine Production Volume, Production Value and Growth Rate of Benzodiazepines (2018-2029)

      • 1.4.5 China Depression Medicine Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.6 China Depression Medicine Production Volume, Production Value and Growth Rate of Monoamine Oxidase Inhibitors (2018-2029)

      • 1.4.7 China Depression Medicine Production Volume, Production Value and Growth Rate of Atypical Antipsychotics (2018-2029)

      • 1.4.8 China Depression Medicine Production Volume, Production Value and Growth Rate of Serotonin-norepinephrine Inhibitors (2018-2029)

    • 1.5 China Depression Medicine Market Analysis by Application from Consumption End

      • 1.5.1 China Depression Medicine Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.2 China Depression Medicine Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

      • 1.5.3 China Depression Medicine Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)

    • 1.6 China Depression Medicine Market Analysis by Region

      • 1.6.1 North China Depression Medicine Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Depression Medicine Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Depression Medicine Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Depression Medicine Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Depression Medicine Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Depression Medicine Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Depression Medicine Market Size and Growth Rate from 2018-2029

    Chapter 2 China Depression Medicine Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Depression Medicine Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Depression Medicine Market Status and Competition Analysis in 2023

      • 2.2.3 China Depression Medicine Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Depression Medicine Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Depression Medicine Industry Development

    Chapter 3 Depression MedicineIndustry Chain Analysis

    • 3.1 Depression Medicine Industry Chain

    • 3.2 Depression Medicine Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Depression Medicine Market

    • 3.3 Depression Medicine Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Depression Medicine Market

    Chapter 4 China Depression Medicine Market, by Type

    • 4.1 China Depression Medicine Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Depression Medicine Total Production Volume and Growth Rate from Production Side

    • 4.5 China Depression Medicine Production Volume and Growth Rate, by Type

      • 4.5.1 China Depression Medicine Production Volume and Growth Rate of Selective Serotonin Reuptake Inhibitors

      • 4.5.2 China Depression Medicine Production Volume and Growth Rate of Tetracyclic Antidepressants

      • 4.5.3 China Depression Medicine Production Volume and Growth Rate of Tricyclic Antidepressants

      • 4.5.4 China Depression Medicine Production Volume and Growth Rate of Benzodiazepines

      • 4.5.5 China Depression Medicine Production Volume and Growth Rate of Others

      • 4.5.6 China Depression Medicine Production Volume and Growth Rate of Monoamine Oxidase Inhibitors

      • 4.5.7 China Depression Medicine Production Volume and Growth Rate of Atypical Antipsychotics

      • 4.5.8 China Depression Medicine Production Volume and Growth Rate of Serotonin-norepinephrine Inhibitors

    Chapter 5 China Depression Medicine Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Depression Medicine Total Market Size and Growth Rate from Consumption End

    • 5.5 China Depression Medicine Market Size and Growth Rate, by Application

      • 5.5.1 China Depression Medicine Market Size and Growth Rate of Others

      • 5.5.2 China Depression Medicine Market Size and Growth Rate of Hospitals

      • 5.5.3 China Depression Medicine Market Size and Growth Rate of Clinics

    Chapter 6 China Depression Medicine Market, by Region

    • 6.1 China Depression Medicine Production Volume and Production Value, by Region

    • 6.2 China Depression Medicine Sales Volume and Sales Value, by Region

    Chapter 7 North China Depression Medicine Market Analysis

    • 7.1 North China Depression Medicine Market, by Type

    • 7.2 North China Depression Medicine Market, by Application

    Chapter 8 Central China Depression Medicine Market Analysis

    • 8.1 Central China Depression Medicine Market, by Type

    • 8.2 Central China Depression Medicine Market, by Application

    Chapter 9 South China Depression Medicine Market Analysis

    • 9.1 South China Depression Medicine Market, by Type

    • 9.2 South China Depression Medicine Market, by Application

    Chapter 10 East China Depression Medicine Market Analysis

    • 10.1 East China Depression Medicine Market, by Type

    • 10.2 East China Depression Medicine Market, by Application

    Chapter 11 Northeast China Depression Medicine Market Analysis

    • 11.1 Northeast China Depression Medicine Market, by Type

    • 11.2 Northeast China Depression Medicine Market, by Application

    Chapter 12 Southwest China Depression Medicine Market Analysis

    • 12.1 Southwest China Depression Medicine Market, by Type

    • 12.2 Southwest China Depression Medicine Market, by Application

    Chapter 13 Northwest China Depression Medicine Market Analysis

    • 13.1 Northwest China Depression Medicine Market, by Type

    • 13.2 Northwest China Depression Medicine Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Janssen Pharmaceuticals

        • 14.1.1 Janssen Pharmaceuticals Company Profile

        • 14.1.2 Janssen Pharmaceuticals Depression Medicine Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Abbott Laboratories

        • 14.2.1 Abbott Laboratories Company Profile

        • 14.2.2 Abbott Laboratories Depression Medicine Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Pfizer

        • 14.3.1 Pfizer Company Profile

        • 14.3.2 Pfizer Depression Medicine Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Naurex

        • 14.4.1 Naurex Company Profile

        • 14.4.2 Naurex Depression Medicine Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 SK Biopharmaceuticals

        • 14.5.1 SK Biopharmaceuticals Company Profile

        • 14.5.2 SK Biopharmaceuticals Depression Medicine Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 GlaxoSmithKline

        • 14.6.1 GlaxoSmithKline Company Profile

        • 14.6.2 GlaxoSmithKline Depression Medicine Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Luye Pharma

        • 14.7.1 Luye Pharma Company Profile

        • 14.7.2 Luye Pharma Depression Medicine Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Otsuka Pharmaceutical

        • 14.8.1 Otsuka Pharmaceutical Company Profile

        • 14.8.2 Otsuka Pharmaceutical Depression Medicine Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Gedeon Richter

        • 14.9.1 Gedeon Richter Company Profile

        • 14.9.2 Gedeon Richter Depression Medicine Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Eli Lilly and Company

        • 14.10.1 Eli Lilly and Company Company Profile

        • 14.10.2 Eli Lilly and Company Depression Medicine Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Novartis

        • 14.11.1 Novartis Company Profile

        • 14.11.2 Novartis Depression Medicine Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 AstraZeneca

        • 14.12.1 AstraZeneca Company Profile

        • 14.12.2 AstraZeneca Depression Medicine Market Performance

        • 14.12.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Depression Medicine Industry Research Conclusions

    • 15.2 Depression Medicine Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Depression Medicine Industry Market Size (2018-2029)

    • Figure China Depression Medicine Production Volume, Production Value and Growth Rate of Selective Serotonin Reuptake Inhibitors (2018-2029)

    • Figure China Depression Medicine Production Volume, Production Value and Growth Rate of Tetracyclic Antidepressants (2018-2029)

    • Figure China Depression Medicine Production Volume, Production Value and Growth Rate of Tricyclic Antidepressants (2018-2029)

    • Figure China Depression Medicine Production Volume, Production Value and Growth Rate of Benzodiazepines (2018-2029)

    • Figure China Depression Medicine Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Depression Medicine Production Volume, Production Value and Growth Rate of Monoamine Oxidase Inhibitors (2018-2029)

    • Figure China Depression Medicine Production Volume, Production Value and Growth Rate of Atypical Antipsychotics (2018-2029)

    • Figure China Depression Medicine Production Volume, Production Value and Growth Rate of Serotonin-norepinephrine Inhibitors (2018-2029)

    • Figure China Depression Medicine Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Depression Medicine Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • Figure China Depression Medicine Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)

    • Figure North China Depression Medicine Market Size and Growth Rate from 2018-2029

    • Figure Central China Depression Medicine Market Size and Growth Rate from 2018-2029

    • Figure South China Depression Medicine Market Size and Growth Rate from 2018-2029

    • Figure East China Depression Medicine Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Depression Medicine Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Depression Medicine Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Depression Medicine Market Size and Growth Rate from 2018-2029

    • Figure Depression Medicine Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Depression Medicine Market Share by Type in 2018

    • Figure China Depression Medicine Market Share by Type in 2023

    • Figure China Depression Medicine Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Depression Medicine Production Volume and Growth Rate of Selective Serotonin Reuptake Inhibitors (2018-2023)

    • Figure China Depression Medicine Production Volume and Growth Rate of Tetracyclic Antidepressants (2018-2023)

    • Figure China Depression Medicine Production Volume and Growth Rate of Tricyclic Antidepressants (2018-2023)

    • Figure China Depression Medicine Production Volume and Growth Rate of Benzodiazepines (2018-2023)

    • Figure China Depression Medicine Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Depression Medicine Production Volume and Growth Rate of Monoamine Oxidase Inhibitors (2018-2023)

    • Figure China Depression Medicine Production Volume and Growth Rate of Atypical Antipsychotics (2018-2023)

    • Figure China Depression Medicine Production Volume and Growth Rate of Serotonin-norepinephrine Inhibitors (2018-2023)

    • Figure China Depression Medicine Market Share by Application in 2018

    • Figure China Depression Medicine Market Share by Application in 2023

    • Figure China Depression Medicine Total Market Size and Growth Rate from Consumption End

    • Figure China Depression Medicine Market Size and Growth Rate of Others (2018-2023)

    • Figure China Depression Medicine Market Size and Growth Rate of Hospitals (2018-2023)

    • Figure China Depression Medicine Market Size and Growth Rate of Clinics (2018-2023)

    • Table China Depression Medicine Production Volume by Region (2018-2023)

    • Table China Depression Medicine Production Volume Share by Region (2018-2023)

    • Figure China Depression Medicine Production Volume Share by Region (2018-2023)

    • Table China Depression Medicine Production Value by Region (2018-2023)

    • Table China Depression Medicine Production Value Share by Region (2018-2023)

    • Figure China Depression Medicine Production Value Share by Region (2018-2023)

    • Table China Depression Medicine Sales Volume by Region (2018-2023)

    • Table China Depression Medicine Sales Volume Share by Region (2018-2023)

    • Figure China Depression Medicine Sales Volume Share by Region (2018-2023)

    • Table China Depression Medicine Sales Value by Region (2018-2023)

    • Table China Depression Medicine Sales Value Share by Region (2018-2023)

    • Figure China Depression Medicine Sales Value Share by Region (2018-2023)

    • Table North China Depression Medicine Production Volume by Type (2018-2023)

    • Table North China Depression Medicine Production Volume Share by Type (2018-2023)

    • Figure North China Depression Medicine Production Volume Share by Type (2018-2023)

    • Table North China Depression Medicine Sales Volume by Application (2018-2023)

    • Table North China Depression Medicine Sales Volume Share by Application (2018-2023)

    • Figure North China Depression Medicine Sales Volume Share by Application (2018-2023)

    • Table Central China Depression Medicine Production Volume by Type (2018-2023)

    • Table Central China Depression Medicine Production Volume Share by Type (2018-2023)

    • Figure Central China Depression Medicine Production Volume Share by Type (2018-2023)

    • Table Central China Depression Medicine Sales Volume by Application (2018-2023)

    • Table Central China Depression Medicine Sales Volume Share by Application (2018-2023)

    • Figure Central China Depression Medicine Sales Volume Share by Application (2018-2023)

    • Table South China Depression Medicine Production Volume by Type (2018-2023)

    • Table South China Depression Medicine Production Volume Share by Type (2018-2023)

    • Figure South China Depression Medicine Production Volume Share by Type (2018-2023)

    • Table South China Depression Medicine Sales Volume by Application (2018-2023)

    • Table South China Depression Medicine Sales Volume Share by Application (2018-2023)

    • Figure South China Depression Medicine Sales Volume Share by Application (2018-2023)

    • Table East China Depression Medicine Production Volume by Type (2018-2023)

    • Table East China Depression Medicine Production Volume Share by Type (2018-2023)

    • Figure East China Depression Medicine Production Volume Share by Type (2018-2023)

    • Table East China Depression Medicine Sales Volume by Application (2018-2023)

    • Table East China Depression Medicine Sales Volume Share by Application (2018-2023)

    • Figure East China Depression Medicine Sales Volume Share by Application (2018-2023)

    • Table Northeast China Depression Medicine Production Volume by Type (2018-2023)

    • Table Northeast China Depression Medicine Production Volume Share by Type (2018-2023)

    • Figure Northeast China Depression Medicine Production Volume Share by Type (2018-2023)

    • Table Northeast China Depression Medicine Sales Volume by Application (2018-2023)

    • Table Northeast China Depression Medicine Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Depression Medicine Sales Volume Share by Application (2018-2023)

    • Table Southwest China Depression Medicine Production Volume by Type (2018-2023)

    • Table Southwest China Depression Medicine Production Volume Share by Type (2018-2023)

    • Figure Southwest China Depression Medicine Production Volume Share by Type (2018-2023)

    • Table Southwest China Depression Medicine Sales Volume by Application (2018-2023)

    • Table Southwest China Depression Medicine Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Depression Medicine Sales Volume Share by Application (2018-2023)

    • Table Northwest China Depression Medicine Production Volume by Type (2018-2023)

    • Table Northwest China Depression Medicine Production Volume Share by Type (2018-2023)

    • Figure Northwest China Depression Medicine Production Volume Share by Type (2018-2023)

    • Table Northwest China Depression Medicine Sales Volume by Application (2018-2023)

    • Table Northwest China Depression Medicine Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Depression Medicine Sales Volume Share by Application (2018-2023)

    • Table Janssen Pharmaceuticals Company Profile

    • Table Janssen Pharmaceuticals Depression Medicine Revenue, Price and Gross (2018-2023)

    • Table Abbott Laboratories Company Profile

    • Table Abbott Laboratories Depression Medicine Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Depression Medicine Revenue, Price and Gross (2018-2023)

    • Table Naurex Company Profile

    • Table Naurex Depression Medicine Revenue, Price and Gross (2018-2023)

    • Table SK Biopharmaceuticals Company Profile

    • Table SK Biopharmaceuticals Depression Medicine Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline Company Profile

    • Table GlaxoSmithKline Depression Medicine Revenue, Price and Gross (2018-2023)

    • Table Luye Pharma Company Profile

    • Table Luye Pharma Depression Medicine Revenue, Price and Gross (2018-2023)

    • Table Otsuka Pharmaceutical Company Profile

    • Table Otsuka Pharmaceutical Depression Medicine Revenue, Price and Gross (2018-2023)

    • Table Gedeon Richter Company Profile

    • Table Gedeon Richter Depression Medicine Revenue, Price and Gross (2018-2023)

    • Table Eli Lilly and Company Company Profile

    • Table Eli Lilly and Company Depression Medicine Revenue, Price and Gross (2018-2023)

    • Table Novartis Company Profile

    • Table Novartis Depression Medicine Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca Company Profile

    • Table AstraZeneca Depression Medicine Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US